| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94ff2d78578d95d1e8d3a2233c76188d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-345 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00 |
| filingDate |
2015-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f99c137ff47085319b6d78358e97909
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_afebc8945b0919898e52e6ba29a851d4 |
| publicationDate |
2016-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016073535-A1 |
| titleOfInvention |
Anti-tatar oral care compositions providing crystallisation prevention |
| abstract |
An oral composition is provided comprising at least 0.5% by weight of the composition of pyrophosphate in an orally acceptable carrier, wherein the pyrophosphate is provided by a mixture of disodium pyrophosphate and tetrapotassium pyrophosphate in a ratio from disodium pyrophosphate to tetrapotassium pyrophosphate in the range of from 1:0.4 to 1:1.2 and wherein the pH value of the composition is in the range of from 6.0 to 8.0. The oral composition can be used for prevention and control of tartar and/or calculus formation. |
| priorityDate |
2014-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |